The capsular dynamics of Cryptococcus neoformans

Diane McFadden1, Oscar Zaragoza, Arturo Casadevall

  • 1Department of Medicine, Division of Infectious Disease, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Trends in Microbiology
|September 26, 2006
PubMed

Insights

Cryptococcus neoformans uses a unique polysaccharide capsule for survival, which dynamically changes size and structure during fungal budding. Understanding capsule self-assembly is key to its dynamics and potential therapeutic targeting.

Area of Science:

  • Mycology
  • Immunology
  • Cell Biology

Background:

  • Cryptococcus neoformans is a pathogenic fungus causing severe infections in immunocompromised individuals.
  • Unlike other pathogenic fungi, C. neoformans possesses a crucial polysaccharide capsule for immune evasion and survival.
  • The fungal capsule is a dynamic structure, altering in size and arrangement during cell division (budding).

Purpose of the Study:

  • To review current knowledge on the synthesis, structure, and assembly of the C. neoformans capsule.
  • To highlight unresolved questions concerning capsule growth and dynamic rearrangements.
  • To discuss the role of self-assembly in the capsule's dynamic behavior.

Main Methods:

  • Literature review of recent research on Cryptococcus neoformans capsule.
  • Analysis of studies on fungal capsule synthesis and structure.
  • Discussion of experimental and theoretical models of capsular dynamics.

Main Results:

  • The polysaccharide capsule is essential for C. neoformans virulence and immune system evasion.
  • Capsule size and structure are not static but change dynamically, particularly during budding.
  • Self-assembly is a significant factor influencing the dynamic properties of the fungal capsule.

Conclusions:

  • The dynamic nature of the C. neoformans capsule, driven by self-assembly, is critical for fungal survival and pathogenesis.
  • Further research is needed to fully elucidate capsule synthesis, assembly, and dynamic rearrangements.
  • Understanding these processes may reveal new therapeutic strategies against cryptococcosis.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...